1. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis
- Author
-
Yuji Nakamoto, Shinji Uemoto, Mitsuhiro Kida, Shinya Uchino, Wataru Kimura, Atsushi Kudo, Tsuyoshi Konishi, Masau Sekiguchi, Koichi Hirata, Izumi Komoto, Hisato Igarashi, Robert Yoshiyuki Osamura, Akihiro Sakurai, Hironobu Sasano, Tetsuhide Ito, Nobuyuki Ohike, Takuji Okusaka, Toshihiko Masui, Ippei Matsumoto, Masanori Yamasaki, Noritoshi Kobayashi, Yoshiyuki Majima, Motohiro Kojima, Yasutoshi Kimura, Chigusa Morizane, Nao Fujimori, Robert T. Jensen, Ryuichiro Doi, Masayuki Imamura, Atsuko Kasajima, Satoshi Hirano, Nobumasa Mizuno, Takeshi Aoki, Takao Ohtsuka, Akira Shimatsu, Masafumi Ikeda, Koji Takano, Tomoyuki Okumura, Jun Matsubayashi, Yuichi Sato, Yuichi Ishikawa, Kiyomi Horiuchi, Koji Morita, Susumu Hijioka, Shinichi Abe, Masao Tanaka, Yoshitaka Honma, Taku Aoki, Kazuhiko Nakamura, and Ryoji Kushima
- Subjects
Oncology ,medicine.medical_specialty ,Aftercare ,Guidelines as Topic ,Disease ,Lanreotide ,Malignancy ,Japanese Neuroendocrine Tumor Society ,Metastasis ,chemistry.chemical_compound ,Stomach Neoplasms ,Surgical oncology ,Internal medicine ,Intestinal Neoplasms ,Humans ,Medicine ,MEN1 ,Multiple endocrine neoplasia ,Clinical practice guideline ,Gastroenteropancreatic neuroendocrine neoplasm ,Original Article—Liver, Pancreas, and Biliary Tract ,Everolimus ,business.industry ,Gastroenterology ,medicine.disease ,Pancreatic Neoplasms ,Neuroendocrine Tumors ,chemistry ,business ,medicine.drug - Abstract
Neuroendocrine neoplasms (NENs) are rare neoplasms that occur in various organs and present with diverse clinical manifestations. Pathological classification is important in the diagnosis of NENs. Treatment strategies must be selected according to the status of differentiation and malignancy by accurately determining whether the neoplasm is functioning or nonfunctioning, degree of disease progression, and presence of metastasis. The newly revised Clinical Practice Guidelines for Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs) comprises 5 chapters—diagnosis, pathology, surgical treatment, medical and multidisciplinary treatment, and multiple endocrine neoplasia type 1 (MEN1)/von Hippel–Lindau (VHL) disease—and includes 51 clinical questions and 19 columns. These guidelines aim to provide direction and practical clinical content for the management of GEP-NEN preferentially based on clinically useful reports. These revised guidelines also refer to the new concept of “neuroendocrine tumor” (NET) grade 3, which is based on the 2017 and 2019 WHO criteria; this includes health insurance coverage of somatostatin receptor scintigraphy for NEN, everolimus for lung and gastrointestinal NET, and lanreotide for GEP-NET. The guidelines also newly refer to the diagnosis, treatment, and surveillance of NEN associated with VHL disease and MEN1. The accuracy of these guidelines has been improved by examining and adopting new evidence obtained after the first edition was published. Supplementary Information The online version contains supplementary material available at 10.1007/s00535-021-01827-7.
- Published
- 2021